Masaya Tanno

タンノマサヤ | Masaya Tanno

Affiliation and department：
Job title： Professor

Research field (1)： Other

Research theme for competitive and other funds (15)：

2022 - 2025 ネクロプトーシス実行因子MLKLを標的とした心不全治療の開発
2021 - 2024 AMPデアミナーゼ活性制御機構の解明と糖尿病性心筋症治療への応用
2021 - 2024 Intracellular signal transduction regulating necroptosis of cardiomyocytes
2021 - 2024 Role of non-classical renin-angiotensin system in contrast induced nephropathy
2019 - 2022 Necroptosis-tartgeted therapy for heart failure

Show all

Papers (126)：

Masaki Shimizu, Wataru Ohwada, Toshiyuki Yano, Hidemichi Kouzu, Tatsuya Sato, Toshifumi Ogawa, Arata Osanami, Yuki Toda, Hiroshi Nagahama, Masaya Tanno, et al. Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin. Journal of pharmacological sciences. 2024. 156. 1. 9-18
Yuki Toda, Sang-Bing Ong, Toshiyuki Yano, Atsushi Kuno, Hidemichi Kouzu, Tatsuya Sato, Wataru Ohwada, Yuki Tatekoshi, Toshifumi Ogawa, Masaki Shimizu, et al. Downregulation of Mitochondrial Fusion Protein Expression Affords Protection from Canonical Necroptosis in H9c2 Cardiomyoblasts. International Journal of Molecular Sciences. 2024. 25. 5. 2905-2905
清水将輝, 大和田渉, 矢野俊之, 神津英至, 佐藤達也, 長南新太, 小川俊史, 戸田悠貴, 久野篤史, 丹野雅也, et al. Contribution of MLKL to the Development of Doxorubicin-induced Cardiomyopathy(タイトル和訳中). 日本循環器学会学術集会抄録集. 2024. 88回. PJ073-1
戸田悠貴, 矢野俊之, 久野篤史, 丹野雅也, 神津英至, 佐藤達也, 大和田渉, 舘越勇輝, 小川俊史, 清水将輝, et al. Impact of Mitochondrial Dynamics on Necroptosis in Cardiomyocytes(タイトル和訳中). 日本循環器学会学術集会抄録集. 2024. 88回. PJ080-3
Tetsuji Miura, Hidemichi Kouzu, Masaya Tanno, Yuki Tatekoshi, Atsushi Kuno. Role of AMP deaminase in diabetic cardiomyopathy. Molecular and Cellular Biochemistry. 2024

ｍore...

MISC (179)：

Arata Osanami, Masaya Tanno, Atsushi Kuno, Hidemichi Kouzu, Toshiyuki Yano, Tatsuya Sato, Tetsuji Miura, Toshifumi Ogawa. AMP Deaminase in Mitochondria-Associated ER Membranes Contributes to Reduction of the Threshold for Mitochondrial Permeability Transition in Type 2 Diabetic Hearts. CIRCULATION. 2021. 144
丹野雅也, 長南新太, 小川俊史, 神津英至. Emerging roles of AMP deaminase in the pathophysiology of diabetic cardiomyopathy. Bio Clinica. 2021. 36. 8. 762-767
Ogawa Toshifumi, Kouzu Hidemichi, Osanami Arata, Tatekoshi Yuki, Mizuno Masashi, Kuno Atsushi, Sugawara Hirohito, Fujita Yugo, Ino Shoya, Ohwada Wataru, et al. AMPデアミナーゼによる心臓分岐鎖アミノ酸代謝の新規制御糖尿病性心筋症の治療標的としての期待(Novel Regulation of Cardiac Branched-chain Amino Acid Metabolism through AMP Deaminase: A Possible Therapeutic Target for Diabetic Cardiomyopathy). 日本循環器学会学術集会抄録集. 2021. 85回. OE081-3
高橋遼, 國分宣明, 小山雅之, 岸上直広, 中田潤, 西川諒, 村上直人, 永野伸卓, 丹野雅也, 大西浩文, et al. Relationship between Risk Factor Management and Lesion Distribution in Coronary Artery Stenosis: A Cross-sectional Analysis of BOREAS-CAG Registry Data(和訳中). 日本循環器学会学術集会抄録集. 2021. 85回. OJ06-3
丹野雅也, 神津英至, 三浦哲嗣. 糖尿病性心筋症の病態・治療の現状とこれから. 糖尿病学の進歩. 2021. 55th

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page